Salvage chemotherapy for ovarian cancer recurrence: Weekly cisplatin in combination with epirubicin or etoposide
Authors:
- Flavia ZanaboniFZFlavia Zanaboni
- Giovanna ScarfoneGSGiovanna Scarfone
- Mauro PrestiMPMauro Presti
- Renato MaggiRMRenato Maggi
- Caterina BorelloCBCaterina Borello
- Giorgio BolisGBGiorgio Bolis
- 1 October 1991
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 43 (1) , 24-28
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compoundsGynecologic Oncology, 1990
- Randomized Trial in Advanced Ovarian Cancer Comparing Cisplatin and CarboplatinJNCI: Journal of the National Cancer Institute, 1989
- Randomized trial comparing two combination chemotherapy regimens (CHAP-5 v CP) in advanced ovarian carcinoma.Journal of Clinical Oncology, 1987
- A prospective randomized trial comparing high-dose cisplatin with low-dose cisplatin and chlorambucil in advanced ovarian carcinoma.Journal of Clinical Oncology, 1986
- Recurrent ovarian carcinoma: Retreatment utilizing combination chemotherapy including cis-diamminedichloroplatinum in patients previously responding to this agentGynecologic Oncology, 1985
- Cis-platin based combination chemotherapy for advanced ovarian cancer. High overall response rate with curative potential only in women with small tumor burdensCancer, 1983
- USE OF HIGH DOSE CIS‐DICHLORODIAMMINE PLATINUM (II) (NSC—119875)† FOLLOWING FAILURE ON PREVIOUS CHEMOTHERAPY FOR ADVANCED CARCINOMA OF THE OVARYBJOG: An International Journal of Obstetrics & Gynaecology, 1981
- Improved chemotherapy for ovarian cancer with cis-diamminedichloroplatinum and adriamycinCancer, 1981